Funding

#Biotechnology #Europe #Funding #Venture funds

European biotech venture builder Kurma closes €215m fund

Kurma Partners, a European healthcare venture capital firm, has announced the final closing of Biofund IV at €215 million.   The new fund will support the discovery and development of disruptive therapeutic solutions for severe or incurable diseases.   Building on the €160 million Biofund III, this successful fundraise has increased the… Read More

#Business & Investment #News

gut epithelium
#Funding #Metabolic diseases #Pancreatic cancer #Seaport Therapeutics

$15m supports first oral therapy to restore gut lymphatic function

Seaport Therapeutics has received an award of up to $15 million to advance its GlyphCele, from the Advanced Research Projects Agency for Health (ARPA-H), in collaboration with the Monash Institute of Pharmaceutical Sciences (MIPS).  GlyphCele is an investigational Glyphed oral prodrug of the COX-2 inhibitor celecoxib, which is designed to… Read More

#Business & Investment #News

Neuron
#Funding #Lario Therapeutics #Neuroscience #Parkinson's #The Michael J Fox Foundation for Parkinson’s Research (MJFF)

$2.4m funds neuronal calcium channel platform for Parkinson’s

Lario Therapeutics has received a total of $2.4 million in grant funding from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) and Wellcome to support the continued expansion of its neuronal calcium channel drug discovery platform.  With the proceeds of these awards, Lario is expanding its work in Parkinson’s… Read More

#Business & Investment #News

#Bill & Melinda Gates Foundation #Biologics #Evotec #Funding #Infectious diseases #Monoclonal antibodies

Grant supports Evotec’s AI-driven optimisation of mAbs

Evotec subsidiary Just – Evotec Biologics has received a new grant from the Gates Foundation to enable global access to biotherapeutics utilising its molecular design suite of computational technologies, called J.MD.  The investment continues the support for selected Gates Foundation grantees to improve the developability and reduce the cost of… Read More

#Business & Investment #News

#AbbVie #Funding #Pioneer Group

They’ve got a Golden Ticket: Alceus Bio wins 2025 initiative 

Biotechnology company Alceus Bio has been awarded Pioneer Group and AbbVie’s 2025 Golden Ticket.  The company, a developer of synthetic chimeric antigen receptor T-lymphocyte therapies for solid malignancies, was chosen as the winner after an extensive selection process.  The Golden Ticket provides a significant package of… Read More

#News

University of Birmingham
#Autoimmune disease #Collaboration #Funding #Immune system #Osaka University #University of Birmingham #University of Oxford

Birmingham Uni and Nobel winner secure inflammation funding

Scientists and clinician-scientists at the University of Birmingham will lead a major research programme to transform the treatment of autoimmune diseases by halting chronic inflammation at its source.  Backed by a £3.83 ($5.1) million Wellcome Discovery Award, Birmingham researchers will join 2025 Nobel Prize winner Professor Shimon… Read More

#News

#Drug discovery #Funding #Neuroscience #Parkinson's #The Michael J Fox Foundation for Parkinson’s Research (MJFF)

Lys Therapeutics awarded $5m to advance neuro pipeline  

French biotech Lys Therapeutics has received a grant award of $5 million (£3.6 million) from The Michael J Fox Foundation for Parkinson’s Research (MJFF) to accelerate the clinical development of its first-in-class monoclonal antibody for the treatment of Parkinson’s disease and other neurodegenerative disorders.  The funding… Read More

#News

#Clinical trials #Drug discovery #Funding #Immunology / Virology & Vaccines #Obesity

This week in drug discovery 1-5 September

News round-up for 1-5 September by DDW Editor Reece Armstrong. There have been a number of stories this week promoting promising science in the areas of obesity and cardiology, along with a partnership to advance vaccine science. The top stories Research programme represents a “new frontier in vaccine… Read More

#News

Funding concept
#Clinical trial #Funding #LIfT BioSciences #Oncology #Solid tumours

LIfT BioSciences receives €12m to support solid tumour trials

LIfT BioSciences has received a grant of €12 million from Ireland’s Disruptive Technologies Innovation Fund (DTIF) to advance its Immuno-Modulatory Alpha Neutrophils (IMANs), designed to overcome treatment resistance in solid tumours, through first-in-human clinical trials expected to start in Q4 2026.  The €12 million grant, the largest grant awarded by… Read More

#Business & Investment #News

#Financing #Funding #MapLight Therapeutics #Neuroscience

MapLight Therapeutics makes $372.5m in series D financing

MapLight Therapeutics has announced an oversubscribed $372.5 million Series D financing.   The financing was co-led by Forbion and Life Sciences at Goldman Sachs Alternatives, with participation from additional new investors, including Sanofi, accounts advised by T Rowe Price Investment Management, Inc. and Avego BioScience Capital.   The financing also included strong… Read More

#Business & Investment #News

#Denmark #Drug development #Funding #Obesity #Pila Pharma #Type 2 diabetes #Weight loss

Biotech raises capital for new oral obesity treatment

Biotech company Pila Pharma has raised 20 million Swedish kronor ($2.08 million) in an almost fully covered capital raise, which includes a stock option for future use. Pila Pharma was founded by Danish researcher Dorte Gram, a former researcher at Novo Nordisk and was the first researcher to screen and… Read More

#Business & Investment #News

#Biomedical research #Drug discovery #European Union #Funding #Optibrium #Sustainability

EU-Funded PhD programme to advance sustainable drug discovery

Optibrium has partnered with Tallinn University of Technology (TalTech) to co-supervise an EU-funded PhD position as part of the INNOCHEMBIO programme1. This research project will focus on developing more accurate metabolism models that will reduce the reliance on costly laboratory experiments while improving speed, efficiency and sustainability in drug discovery. Read More

#News

#Defense Innovation Agency (AID) #Funding #Human pathogens #National Research Agency (ANR) #Therapeutics #Tropical disease

Grant funding worth nearly €800,000 to develop antiviral awarded

France’s National Research Agency (ANR) and Defense Innovation Agency (AID) will finance the BUNYANTIVIR project to introduce a novel therapeutic approach for Bunyaviricetes’ class of human pathogenic viruses found in tropical and subtropical regions. The BUNYANTIVIR project has been selected under the call for proposals for the 2024 ASTRID Maturation… Read More

#News

Seed fund
#Funding #Obesity #Seed funding #Start-ups #University of Michigan #Weight loss

Weight loss start-up secures $7.8m investment

University of Michigan (U-M) spinout company Courage Therapeutics has received a seed investment of up to $7.8 million from Arsenal Bridge Ventures.  The investment will enable Courage Therapeutics to complete essential testing and development to advance its drug candidates to clinical trials.   The company’s two drug development programmes aim to… Read More

#Business & Investment #News #Start-up Zone

#Colorectal cancer #Funding #Oncology #Start-ups #University of Arizona #University of Dundee

Start-up receives $4m towards ‘one-shot’ cancer drug

A drug discovery company co-founded by researchers at the University of Dundee and the University of Arizona has received $4 million in venture funding.  Branch Therapeutics, founded in November 2024, is a preclinical stage company seeking to develop drugs that are orally bioavailable, well-tolerated, and can treat multiple cancer types. … Read More

#Business & Investment #Cancer Research #News #Start-up Zone

EU flag
#European Commission #European Union #Funding #Research and development

EC urges researchers to “choose Europe for science”

European Commission President Ursula von der Leyen has announced new funding ‘super grants’ at the ‘Choose Europe for Science’ conference.  The substantial additional budget for the development of larger, longer-term grants has been welcomed by the Scientific Council of the European Research Council (ERC).   As… Read More

#News #Trending News